![Samaritan Pharmaceuticals Company Logo](/news-release/logo/216057/0/216057.jpg?lastModified=12%2F09%2F2016%2022%3A56%3A06&size=2)
Samaritan's Collaborating Scientist to Become McGill's New Research Star
November 30, 2006 10:49 ET
|
Samaritan Pharmaceuticals, Inc.
LAS VEGAS, Nov. 30, 2006 (PRIME NEWSWIRE) -- Samaritan Pharmaceuticals Inc. (AMEX:LIV) a developer of innovative drugs, is pleased to announce today that Dr. Vassilios Papadopoulos, the lead scientist...
![Samaritan Pharmaceuticals Company Logo](/news-release/logo/216057/0/216057.jpg?lastModified=12%2F09%2F2016%2022%3A56%3A06&size=2)
United States Patent Application Published for Samaritan's Novel Alzheimer's Drug SP-04
November 21, 2006 10:06 ET
|
Samaritan Pharmaceuticals, Inc.
LAS VEGAS, Nov. 21, 2006 (PRIMEZONE) -- Samaritan Pharmaceuticals, Inc. (AMEX:LIV) a developer of innovative drugs, announced today they received notice of the publication of its novel Alzheimer's...
![Technology Innovation Award](http://www.globenewswire.com/en/Attachment/LogoDisplay/216313?filename=216313.jpg&size=2)
Photo Release -- Samaritan Recognized for HIV Innovation
November 16, 2006 11:01 ET
|
Samaritan Pharmaceuticals, Inc.
LAS VEGAS, Nov. 16, 2006 (PRIMEZONE) -- Samaritan Pharmaceuticals Inc. and Samaritan PharmaPlaz Ireland, Inc. (AMEX:LIV) a developer of innovative drugs, announced today it has been selected by the...
![Samaritan Pharmaceuticals Company Logo](/news-release/logo/216057/0/216057.jpg?lastModified=12%2F09%2F2016%2022%3A56%3A06&size=2)
Samaritan Arrives at Definitive Agreement to Acquire Metastatin to Expand Cancer Pipeline
November 14, 2006 14:46 ET
|
Samaritan Pharmaceuticals, Inc.
LAS VEGAS, Nov. 14, 2006 (PRIMEZONE) -- Samaritan Pharmaceuticals Inc. (AMEX:LIV) a developer of innovative drugs, is pleased to announce today that Samaritan has reached a definitive agreement to...
![Samaritan Pharmaceuticals Company Logo](/news-release/logo/216057/0/216057.jpg?lastModified=12%2F09%2F2016%2022%3A56%3A06&size=2)
Samaritan Receives AMEX Compliance Notice Letter
November 13, 2006 11:04 ET
|
Samaritan Pharmaceuticals, Inc.
LAS VEGAS, Nov. 13, 2006 (PRIMEZONE) -- Samaritan Pharmaceuticals Inc. (AMEX:LIV) announced today, that on November 6, 2006, it received a notice from the American Stock Exchange, Inc. ("AMEX")...
![Samaritan Pharmaceuticals Company Logo](/news-release/logo/216057/0/216057.jpg?lastModified=12%2F09%2F2016%2022%3A56%3A06&size=2)
Samaritan Submits IND to FDA for Novel Anti-Amyloidal Alzheimer's Drug Candidate Caprospinol
November 06, 2006 09:12 ET
|
Samaritan Pharmaceuticals, Inc.
LAS VEGAS, Nov. 6, 2006 (PRIMEZONE) -- Samaritan Pharmaceuticals Inc. and Samaritan Pharma Ireland, Inc. (AMEX:LIV) developers of innovative drugs, announced today it has submitted an Investigational...
![Samaritan Pharmaceuticals Company Logo](/news-release/logo/216057/0/216057.jpg?lastModified=12%2F09%2F2016%2022%3A56%3A06&size=2)
International Patent Application Published for Samaritan's Novel Alzheimer's Drug Caprospinol
November 03, 2006 10:27 ET
|
Samaritan Pharmaceuticals, Inc.
LAS VEGAS, Nov. 3, 2006 (PRIMEZONE) -- Samaritan Pharmaceuticals Inc. (AMEX:LIV) a developer of innovative drugs, announced today we have received notice of the publication of its novel anti-amyloidal...
![HIV Entry Inhibitor Drug SP-01A](http://www.globenewswire.com/en/Attachment/LogoDisplay/216278?filename=216278.jpg&size=2)
Photo Release -- Samaritan Completes Patient Enrollment in Proof of Concept PIIb Clinical Trial for HIV Entry Inhibitor Drug SP-01A
November 01, 2006 03:10 ET
|
Samaritan Pharmaceuticals, Inc.
LAS VEGAS, Nov. 1, 2006 (PRIMEZONE) -- Samaritan Pharmaceuticals Inc. (AMEX:LIV), a developer of innovative drugs, announced today it has completed patient enrollment of its Phase IIb (Stage 2) 28 day...
![Samaritan Pharmaceuticals Company Logo](/news-release/logo/216057/0/216057.jpg?lastModified=12%2F09%2F2016%2022%3A56%3A06&size=2)
Samaritan to Highlight Oral HIV Entry Inhibitor and Novel Alzheimer's Drug At BioPartnering Europe to Seek Partnering Opportunities
October 03, 2006 09:30 ET
|
Samaritan Pharmaceuticals, Inc.
LAS VEGAS, Oct. 3, 2006 (PRIMEZONE) -- Samaritan Pharmaceuticals Inc. (AMEX:LIV), a developer of innovative drugs, announced today, it will highlight the uniqueness and advantages of its oral HIV...
![Samaritan Pharmaceuticals Company Logo](/news-release/logo/216057/0/216057.jpg?lastModified=12%2F09%2F2016%2022%3A56%3A06&size=2)
Taglich Brothers Issues Updated Research Report On Samaritan Pharmaceuticals
September 19, 2006 10:39 ET
|
Samaritan Pharmaceuticals, Inc.
LAS VEGAS, Sept. 19, 2006 (PRIMEZONE) -- Samaritan Pharmaceuticals Inc. (AMEX:LIV), a developer of innovative drugs, announced today that Taglich Brothers published an updated Samaritan...